Key result
TAM receptors modulate cardiovascular disease through efferocytosis, inflammation, and vascular remodeling.
Answers are grounded in this paper and cite their sources.
The TAM receptors are a distinct family of three receptor tyrosine kinases, namely Tyro3, Axl, and MerTK. Since their discovery in the early 1990s, they have been studied for their ability to influence numerous diseases, including cancer, chronic inflammatory and autoimmune disorders, and cardiovascular diseases. The TAM receptors demonstrate an ability to influence multiple aspects of cardiovascular pathology via their diverse effects on cells of both the vasculature and the immune system. In this review, we will explore the various functions of the TAM receptors and how they influence cardiovascular disease through regulation of vascular remodelling, efferocytosis and inflammation. Based on this information, we will suggest areas in which further research is required and identify potential targets for therapeutic intervention.
No takes yet. Share an insight, caveat, or question.
McShane et al. (2019) conducted a review in Cardiovascular disease. TAM receptors (Tyro3, Axl, and MerTK) was evaluated. TAM receptors (Tyro3, Axl, and MerTK) influence cardiovascular pathology by regulating vascular remodelling, efferocytosis, and inflammation.
Synapse has enriched 10 related papers. Consider them for comparative context: